MiMARK Diagnostics, member of CataloniaBio & HealthTech, has successfully raised a total of 1.2 million euros for an innovative project focused on the diagnosis of endometrial cancer. 

The collection was thanks to the investment of CDTI Innovación - Centro para el Desarrollo Tecnológico y la Innovación, and with the collaboration of Nara Health Capital. 

“Your support is an invaluable asset, and we are very grateful for your partnership. We are taking significant steps towards a revolution in gynaecological diagnostics” - MiMark Diagnostics. 

Related news: 

• MiMARK Diagnostics receives €2.5 M from the European Innovation Council Accelerator